SciELO - Scientific Electronic Library Online

 
vol.118 issue5Thyroid stimulating hormone levels in cord blood are not influenced by non-thyroidal mothers' diseasesVanishing bile duct syndrome in Hodgkin's disease: case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Sao Paulo Medical Journal

Print version ISSN 1516-3180On-line version ISSN 1806-9460

Sao Paulo Med. J. vol.118 n.5 São Paulo Sept. 2000

http://dx.doi.org/10.1590/S1516-31802000000500007 

Original Article


• Vânia Aparecida Leandro-Merhi • Maria Marluce dos Santos Vilela
• Marcos Nolasco da Silva • Fábio Ancona Lopez
• Antônio de Azevedo Barros Filho

 

Evolution of nutritional status of infants infected with the human immunodeficiency virus
Pediatric Immunodeficiency Service, Department of Pediatrics, Faculty of Medical Sciences, Universidade Estadual de Campinas, Campinas, Brazil.

 

 

ABSTRACT

CONTEXT: There are today only a limited number of studies defining growth parameters and nutritional status for HIV children.
OBJECTIVE: To study the nutritional status of infants infected with the human immunodeficiency virus.
TYPE OF STUDY: Longitudinal study.
SETTING: Department of Pediatrics, Faculty of Medical Sciences, UNICAMP, Campinas, Brazil.
PARTICIPANTS: One hundred and twenty-four children born to HIV infected mothers were evaluated from birth until the age of two years. They were subdivided into two groups: 71 infected children and 53 non-infected children.
MAIN MEASUREMENTS: Growth was evaluated in both groups by comparing Z-scores for weight/age (w/a), length/age (H/a) and weight/length (w/H) (using the NCHS curves as reference).
RESULTS: The Z-score analyses showed that there was a significant difference between the two groups for all the variables studied, except for the H/a value at 3 months of age and the W/H value at 21 months of age, which showed P > 0.05.
CONCLUSIONS: The growth of infected infants was observed to be severely affected in comparison with that of seroreversed infants in the same age groups. Although clinical manifestations may take time to appear, the onset of growth changes begin soon after birth.
KEY WORDS: Growth and development. Nutritional status. Children. HIV. Acquired immunodeficiency syndrome.

 

 

INTRODUCTION

AIDS has caused a tremendous impact ever since the first adult and child cases were reported at the Center for Disease Control, Atlanta, USA1 and has become one of the greatest health problem all over the world. According to the estimates in 1994, there were approximately 2 million children infected with HIV in the world. In the United States of America, there are 12,000 infected children.2

As the number of heterosexual men infected increased, the number of women and children infected also increased. In 1985, the highest number of AIDS cases reported was among homosexuals followed by bisexuals, drug addicts and lastly heterosexuals. In 1987, most of the cases reported were heterosexuals, followed by homosexuals and endovenous drug addicts.3 Consequently, the number of cases of AIDS in children increased. There was an improvement in the notification of cases when pre-natal follow-up of the mothers was conducted with later follow-up of the children. In comparison with the 1990's, the number of infected women has increased and as a result the number of infected children has also risen. In September 1993, there were 4,906 pediatric cases of AIDS diagnosed in the United States ¾ 88% were due to perinatal transmission from the infected mother and 11% were as a result of contaminated blood transfusions.4 According to the World Health Organization, by the year 2000, approximately 40 million adults and 2 million children will have been infected with HIV.5

In Brazil, the first cases of AIDS in children were reported in 1983 and almost all of them were infected by blood transfusions or by the transfusion of its derivatives.3

Up to August 1998, there had been 140,362 cases of AIDS reported in Brazil. Of these, 4815 (3.4%) were children below the age of 13, which demonstrated that in this age group there had been an increase in this disease. Among infant cases, 3825 (79.4%) acquired the disease through vertical transmission, 205 (4.3%) were hemophiliacs, 279 (5.8%) acquired it through transfusions and 489 (10.2 %) from unknown sources, and 1986 (41.2%) of these infant cases had died.3

The clinical manifestations generally shown by such children are: generalized lymphadenopathy, hepatosplenomegaly, oral candidiasis and recurring infections.6-9

There are today only a limited number of studies defining growth parameters for HIV children.10,11 Halsey, et al.12 (1990), studied a population sample in Haiti and found that the weight of the babies born to mothers positive for HIV type were similar, independent of the state of infection during that period, but different from the weight of babies born to mothers negative for HIV type. Although the ingestion of nutrients and the body mass were not reported, the weight of children positive for HIV at 3 months differed from the weight of children seronegative for HIV and the HIV negative control group. Miller, et al.10 (1993) observed that at birth, normal children and HIV infected children had similar weight, gestational age and percentile weight but at between 19 and 21 months, their percentile weights differed significantly and the lengths remained the same. McKinney, et al.11 (1993) analyzed the growth rate of children during the first two years of life and found that the growth index of HIV infected children during the first four months was significantly less than that of non-infected children regarding weight as well as length in relation to age and that the linear growth as well as the gain in weight were proportionally reduced. Moye, et al.13 (1996) studied the magnitude of the infection caused by the human immunodeficiency virus, acquired either perinatally or congenitally, on somatic growth from birth up to the age of 18 months. They concluded that the infected children showed a progressive decline in body mass index from birth to the age of 6 months.

Growth monitoring is an important tool for evaluating the child's health. We were able to study this question profoundly because of the information available regarding the weight and length of seroreversed infected children, who were being treated at the Outpatient Pediatrics Department, Hospital das Clínicas, State University of Campinas, SP, Brazil. The objective of this research was to study the nutritional status with regard to weight and length of children with the human immunodeficiency virus aged zero to 24 months, and to compare these results with those of non-infected children with mothers who were positive for HIV.

 

METHODS

The procedures that follow were in accordance with the ethical standards of the committee responsible for human experimentation and with the Helsinki declaration of 1975, as revised in 1993.

Design

A mixed longitudinal study was conducted during the follow-up period from August 1985 to April 1996.

Setting

Department of Pediatrics, State University of Campinas.

Participants

Children whose mothers were found to be positive for HIV at the Outpatient Department, Pediatric Immunodeficiency Service, Hospital das Clínicas, State University of Campinas. The following variables were analyzed: age, sex, gestational age at birth, weight at birth, weight and length during the follow-up period. The study was conducted on 124 patients who fulfilled the criteria established. Children who weighed less than 2500g and those who started treatment after the age of two years were excluded.

The criteria for inclusion were:

a) Born after full gestational term and with weight ³ 2500 g.16

b) Absence of congenital diseases that could interfere in the development of the child and its nutritional state.

c) Only vertically infected children were included (mother ® child).

The children were classified into two groups:

a) Infected Children: those children who were serologically positive for the human immunodeficiency virus after conducting the enzyme-linked immunoabsorbent assay (ELISA) and confirmed by the Western Blot or Immunofluorescence test after the age of 18 months or before this date, if the child showed symptoms of the disease.

b) Non-infected Children (seroreversed): the children were considered to be non-infected when they showed a complete reversal of the serological results (ELISA) up to 18 months of age, with normal immunology and without any symptoms of the human immunodeficiency virus infection.

Main Measurements

Anthropometry. A nutritional evaluation was conducted with the help of weight and length measurements and utilizing the curves of the "National Center for Health Statistics",14 which have been recommended by the World Health Organization (WHO). The relationships weight/length, length/age and weight/age were expressed in terms of "Z-scores".15 In order to analyze the Z scores, children between the ages of zero and 24 months and infected with the human immunodeficiency virus were chosen, and also children between zero and 24 months who were seropositive at the beginning and became negative by the age of 18 months.

Statistical Methods

The Student T test was used in the case of independent samples when the normality supposition was satisfied and the Mann-Whitney U test was used for the rest. The tests were conducted for a 5% significance (a) level.

The patients were classified according to their ages for statistical analysis:

a) Between 0 and 6 months: The measurements closest to three months were taken for the calculation of the Z-scores.

b) Between 6 and 12 months: The measurements closest to nine months were taken for the calculation of the Z-scores.

c) Between 12 and 18 months: The measurements closest to fifteen months were taken for the calculation of the Z-score.

d) Between 18 and 24 months: The measurements closest to twenty-four months were taken for the calculation of the Z-score.

Z-scores were calculated for weight/age, length/age and weight/length in the cases of both the infected and the non-infected groups of children.

 

RESULTS

The children were divided into two groups ¾ infected and non-infected ¾ and classified according to their sex, color, mother's education, type of birth and whether they were breast-fed (Table 1).

It was observed that with regard to the sex of children in the infected group, 34 children (47.9%) were male and 37 (52.1%) were female. In the case of non-infected children, 31 (58.5%) were males and 22 (41.5%) were females. During the survey period, the follow-up service at the Pediatric Immunodeficiency Department was regularly used by 32 infected children (45.1%); 13 children (18.4%) abandoned the follow-up; 3 children (4.2%) were transferred to another service and 23 children (32.4%) died. Thirteen of the children (56.5%) who died did so before the age of 2, and 10 children (43.4%) died after the age of 2. The infected children reported at the clinic according to the evolution of the disease, which was usually weekly. In the group of non-infected children, 30 children (56.6%) had a regular follow up, 10 children (18.8%) abandoned the program, 1 child (1.9%) was transferred to another program and 12 (22.6%) children were discharged. None of the children from this group died. Most of the children came from a background of low income and mother's education.

Table 2 shows the distribution of the children in the infected and non-infected groups with regard to the weight and length at birth and gestational age.

 

 

It was verified that the weight and length at birth and the gestational age were similar for the two groups.

The results of the Z-score analyses are shown in Table 3. It can be seen that there is a difference between all the variables for both groups except in the case of length/age at 3 months and weight/length at 21 months as the value obtained for P was > 0.05.

 

DISCUSSION

The analysis of the growth of children born to HIV+ mothers reveals the social and affective factors involved in these children's families. Children of HIV+ mothers are raised in an environment highly affected by the disease and the circumstances that follow it. The children that develop infection have a path of highs and lows depending of the availability of the treatment and the response that each patient presents to this treatment. This work refers to children treated before the recently proposed drug therapy, and the objective of this study was not, at this time, to evaluate the effect of clinical treatment on the patients.

HIV can be transmitted vertically during pregnancy, at birth and or during breast feeding. According to the clinical data, at least 50% of the transmissions seem to occur at birth. This supposition is based on the fact that in the case of most children, it is difficult to detect viral particles during the first weeks of life without the viral multiplication or the formation of antibodies which occurs around the second month.17 It is probably at this stage that the virus comes out of latency and begins the phase of viral replication which is proportional to the stimulus offered by the immune system.

Children born to mothers who are seropositive for HIV, are usually born seropositive because of the passage of antibodies of class IgG through the placenta. The maternal antibodies may remain detectable until the 15th month of life and as a result, the ELISA and the Western Blot tests do not diagnose HIV infection.

A definite diagnosis of infection in children younger than 15 months old can only be done by directly researching the virus or its components: viral cultures, the presence of antigenemia (antigen P24), the polymerase chain reaction (PCR) and viral load.1

The growth of children born to mothers infected with the human immunodeficiency virus was evaluated in this study. Those who developed the infection were compared to the seroreversed children. Both these groups belonged to the same social-economic class. It was observed that the growth of the infected children was already compromised at 3 months. During the first year of life they were proportionally smaller in weight as well as length, although at 3 months the mean length was less in the HIV positive group than in the seroreversed group. At that stage, the difference was still not significant, but showed that weight was compromised earlier than length.

Weight and length measurements have traditionally been used as criteria for determining the nutritional state and health of children.18 Children infected by the human immunodeficiency virus usually have nutritional problems and the "wasting" syndrome was described as a condition that indicated AIDS in 17% of the children in 1994.19 Oleske, et al.20 (1983) and Rubinstein et al21 (1983) have highlighted growth retardation and loss in weight in early reports on children with AIDS, although very little progress has been made during recent years in understanding the mechanism of these observations.

It was observed that there was no difference regarding weight and length at birth and the gestational age between infected and non-infected children. Other studies that have analyzed the growth of HIV infected children have also confirmed the above observation,10,22,23 but there are other researchers who have found differences between the groups.24

Abnormalities in the development of the child most probably begin after birth and take place rapidly, even in asymptomatic children. Growth models are not always foreseeable, as the clinical course of the disease varies.

Other researchers have found that during the pre-natal period, the children infected by the virus showed a reduction in weight/age and length/age when compared with non-infected children during the first four months of life. Reductions in weight and length were proportional resulting in a nearly normal relationship ¾ weight/proximal length.11 In this study, it was observed that the difference in weight when compared with length diminished at 15 months and was not significant at 21 months. With time, length was compromised and the relationship weight/length modified.

The failure to grow is reported in approximately one third of the children infected by the human immunodeficiency virus and is associated with a reduced rate of survival. Loss of weight occurs in the first months of life before there is a decline in the length of children born to mothers infected with the virus. In long term survivors, the reduction in growth continues and may be associated with reduced body mass.

Moye, et al.13 (1996) showed that infected and non-infected children born to infected mothers had similar weight, length and gestational age at birth. However, at the age of 2 months, the infected children revealed a significant reduction in the circumference of the head and in weight, but the length did not diminish significantly until the age of 4 months. These differences were maintained for 18 months.

As the children became more symptomatic, diarrhea, malabsorption and enteric infections became more common and growth was affected.

In short, during the first two years of life, the Z-scores for infected children regarding weight and length in the population studied were less than those for non-infected children. The growth of the children was proportional but their size was inferior when compared to their chronological age. HIV affects the infected children rapidly and is demonstrated by premature growth retardation.

 

CONCLUSION

These results have helped us to reach the conclusion that there was a significant difference with regard to weight and length between the group of infected children and that of non-infected children. On analyzing the Z-score it was observed that there was a significant difference between the two groups with regard to the following indices: length/age at 9, 15 and 21 months; weight/length at 3, 9 and 15 months and weight/age at 3, 9, 15 and 21 months.

 

REFERENCES

1. Cooper ER, Pelton SJ, Lemay M. Acquired ID Syndrome: a new population of children at risk. Pediatr Clin North Am 1988;35(6):1365-8.         [ Links ]

2. Davis SF, Byers RH, Lindegren ML, Caldwell MB, Karon JM, Gwinn M. Prevalence and incidence of vertically acquired HIV infection in the United Stated. JAMA 1995;274:952-5.         [ Links ]

3. Ministério da Saúde. AIDS ¾ Boletim Epidemiológico. Ano XI, no. 3, p.33 ¾ Semana Epidemiológica ¾ June-August 1998.         [ Links ]

4. Centers for Disease Control. HIV/AIDS. Surveillance Report 1993;5:1-19.         [ Links ]

5. Anonymous. Update: Acquired immunodeficiency syndrome: United States, 1994. MMWR 1995;44:64-7.         [ Links ]

6. Kamani N, Lightman, H, Leiderman I, Krilov LR. Pediatric acquired immunodeficiency syndrome-related complex: clinical and immunological features. Pediatr Infect Dis J 1998;7:383-8.         [ Links ]

7. Caprilles Quirós JA, Conde JG, Gorrin JJ, Dones OR. Perfil sociodemográfico y medidas del crescimiento físico en pacientes pediátricos com el síndrome de imunodeficiência adquirida seguidos en el Hospital Muncipal de San Juan: 1986-1990. Bol Assoc Med PR 1991;83:479-84.         [ Links ]

8. Rodriguez GEP, Robles, MCG, Gonzalez FT. Síndrome de immunodeficiência adquirida en ninõs. Experiência de 8 anos en el Hospital de Infectologia del Centro Médico "La Raza", Instituto Mexicano del Seguro Social. Bol Méd Hosp Infant Méx 1992;49:581-4.         [ Links ]

9. Prazuck T, Tall F, Nacro B, et al. HIV Infection and severe malnutrition: a clinical and epidemiological study in Burkina Faso. AIDS 1993;7:103-8.         [ Links ]

10. Miller TL, Evans SJ, Orav EJ, Monis V, McIntosh K. Growth and body composition in children infected with the human immunodeficiency virus - 1. Am J Clin Nutr 1993;57:588-92.         [ Links ]

11. McKinney RE Jr, Robertson WR, Duke. Pediatric AIDS Clinical Trials Unit. Effect of human immunodeficiency virus infection on the growth of young children. J Pedriatr 1993;123:579-82.         [ Links ]

12. Halsey NA, Boulos R, Holt E, et al. Transmission of HIV Infections from mothers to infants in Haiti. JAMA 1990;264:2088-92.         [ Links ]

13. Moye J, Rich KC, Kalish LA, et al. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. J Pediatr 1996;128:58-69.         [ Links ]

14. National Center for Health Statistics. Growth curves for children birth 18 years United States. Washington, DC: VS Printing Office, 1977. (Vital and Health Statistics, Series 11, no. 165, DHW Pub. no. 78-1650).         [ Links ]

15. Sullivan K, Gorteins J. Programas para antropometria nutricional. In: Dean AG, De An JA, Burton AH, Dicker RC. EPI INFO, version 5: a world processing database and statistics program for epidemiology microcomputers. Center for Disease Control, Atlanta, Georgia, USA, 1990.         [ Links ]

16. Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967;71:159-63.         [ Links ]

17. Mofenson LM. The role of antiretroviral therapy in the management of HIV infection in women. Clin Obst Gynecol 1996;39(2):361-85.         [ Links ]

18. Waterlow JC. Basic concepts in the determination of nutritional requirements of normal infants. In: Tsang R, Nichols B, editors. Nutrition during infancy. St. Louis: CV Mosby Company; 1988:1-19.         [ Links ]

19. Centers for Disease Control. 1994 Revised classification system for human immunodeficiency virus (HIV) infection in children less than 13 years of age. MMWR 1994;43:1-10.         [ Links ]

20. Oleske J, Minnefore A, Cooper R, et al. Immune deficiency syndrome in children. JAMA 1983;249:2345-9.         [ Links ]

21. Rubinstein A, Sicklick M, Gupta A, et al. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug addicted mothers. JAMA 1983;249:2350-6.         [ Links ]

22. Blanche S, Rouzioux C, Moscto MG. A prospective study of infants born to women seropositive for HIV type 1. N Engl J Med 1989;320:1643-8.         [ Links ]

23. Pollack H, Glasberg H, Lee E, et al. Impaired early growth of infants perinatally infected with human immunodeficiency virus : correlation with viral load. J Pediatric 1997;130:915-22.         [ Links ]

24. Geffner ME, Van Dop C, Kovacs AA, et al. Intrauterine and postnatal growth in children born to women infected with HIV. Pediatric AIDS and HIV infection: Fetus to Adolescent, 1994;5:162-8.         [ Links ]

 

 

RESUMO

CONTEXTO: Atualmente há estudos limitados que definem parâmetros de crescimento e estado nutricional em crianças com HIV.
OBJETIVO: Estudar o estado nutricional de crianças infectadas com o vírus da imunodeficiência humana.
TIPO DE ESTUDO: Estudo longitudinal.
LOCAL: Serviço de imunodeficiência pediátrica da Universidade Estadual de Campinas, Campinas, Brasil.
PARTICIPANTES: 124 crianças nascidas de mulheres infectadas com o HIV foram avaliadas desde o nascimento até dois anos de idade. Elas foram subdivididas em dois grupos: 71 crianças infectadas e 53 crianças não-infectadas.
PROCEDIMENTOS: A avaliação do estado nutricional foi realizada pela comparação do Z-score para peso/idade(P/I),altura/idade(A/I) e peso/altura(P/A),usando as curvas do NCHS como referência. Para a comparação do Z-score foram utilizados os testes T de Student e U de Mann-Whitney. Os testes foram conduzidos ao nível de significância=5%.
RESULTADOS: A análise do Z-score revelou que houve evidência de diferença entre os dois grupos, para todas as variáveis estudadas, exceto o índice de A/I aos 3 meses e P/A aos 21 meses.
CONCLUSÕES: O estado nutricional das crianças infectadas foi gravemente afetado em comparação com as crianças sororreversoras no mesmo grupo de idade. Embora as manifestações clínicas possam demorar a aparecer, as alterações no crescimento surgem logo após o nascimento.
PALAVRAS-CHAVE: Crescimento e desenvolvimento. Estado nutricional. Crianças. HIV. Síndroma da imunodeficiência adquirida.

p

ublishing information

PUBLISING INFORMATION

Vânia Aparecida Leandro-Merhi, MSc. Nutritionist, Department of Nutrition, Pontifícia Universidade Católica de Campinas and Universidade Metodista de Piracicaba, São Paulo, Brazil.
Maria Marluce dos Santos Vilela, PhD. Department of Pediatrics, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil.
Marcos Nolasco da Silva, PhD. Department of Pediatrics, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil.
Fábio Ancona Lopez, PhD. Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil.
Antônio de Azevedo Barros Filho, PhD. Department of Pediatrics, Faculty of Medical Sciences, State University of Campinas, Campinas, Brazil.

Sources of funding: Not declared
Conflict of interest: Not declared
Last received: 14 March 2000
Accepted: 18 April 2000

Address for correspondence:
Vânia Aparecida Leandro-Merhi
Av. José Bonifácio, 1425 - Apto. 72
Campinas/SP - Brazil - CEP 13093-420
E-mail: vania@acad.puccamp.br

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License